These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 12542845

  • 1. Production of recombinant H1 parvovirus stocks devoid of replication-competent viruses.
    Brown CS, DiSumma FM, Rommelaere J, Dege AY, Cornelis JJ, Dinsart C, Spaan WJ.
    Hum Gene Ther; 2002 Dec 10; 13(18):2135-45. PubMed ID: 12542845
    [Abstract] [Full Text] [Related]

  • 2. Construction and production of oncotropic vectors, derived from MVM(p), that share reduced sequence homology with helper plasmids.
    Clément N, Velu T, Brandenburger A.
    Cancer Gene Ther; 2002 Sep 10; 9(9):762-70. PubMed ID: 12189526
    [Abstract] [Full Text] [Related]

  • 3. Highly efficient transduction and expression of cytokine genes in human tumor cells by means of autonomous parvovirus vectors; generation of antitumor responses in recipient mice.
    Haag A, Menten P, Van Damme J, Dinsart C, Rommelaere J, Cornelis JJ.
    Hum Gene Ther; 2000 Mar 01; 11(4):597-609. PubMed ID: 10724038
    [Abstract] [Full Text] [Related]

  • 4. Autonomous parvovirus vectors: preventing the generation of wild-type or replication-competent virus.
    Brandenburger A, Velu T.
    J Gene Med; 2004 Feb 01; 6 Suppl 1():S203-11. PubMed ID: 14978763
    [Abstract] [Full Text] [Related]

  • 5. A novel MVMp-based vector system specifically designed to reduce the risk of replication-competent virus generation by homologous recombination.
    Dupont F, Karim A, Dumon JC, Mine N, Avalosse B.
    Gene Ther; 2001 Jun 01; 8(12):921-9. PubMed ID: 11426332
    [Abstract] [Full Text] [Related]

  • 6. Encapsidation of a recombinant LuIII parvovirus genome by H1 virus and the fibrotropic or lymphotropic strains of minute virus of mice.
    Maxwell IH, Long CJ, Carlson JO, Rhode SL, Maxwell F.
    J Gen Virol; 1993 Jun 01; 74 ( Pt 6)():1175-9. PubMed ID: 8509766
    [Abstract] [Full Text] [Related]

  • 7. Potentiation of a recombinant oncolytic parvovirus by expression of Apoptin.
    Olijslagers S, Dege AY, Dinsart C, Voorhoeve M, Rommelaere J, Noteborn MH, Cornelis JJ.
    Cancer Gene Ther; 2001 Dec 01; 8(12):958-65. PubMed ID: 11781658
    [Abstract] [Full Text] [Related]

  • 8. Effective infection, apoptotic cell killing and gene transfer of human hepatoma cells but not primary hepatocytes by parvovirus H1 and derived vectors.
    Moehler M, Blechacz B, Weiskopf N, Zeidler M, Stremmel W, Rommelaere J, Galle PR, Cornelis JJ.
    Cancer Gene Ther; 2001 Mar 01; 8(3):158-67. PubMed ID: 11332986
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chimeric and pseudotyped parvoviruses minimize the contamination of recombinant stocks with replication-competent viruses and identify a DNA sequence that restricts parvovirus H-1 in mouse cells.
    Wrzesinski C, Tesfay L, Salomé N, Jauniaux JC, Rommelaere J, Cornelis J, Dinsart C.
    J Virol; 2003 Mar 01; 77(6):3851-8. PubMed ID: 12610161
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficient recombinant parvovirus production with the help of adenovirus-derived systems.
    El-Andaloussi N, Leuchs B, Bonifati S, Rommelaere J, Marchini A.
    J Vis Exp; 2012 Apr 23; (62):. PubMed ID: 22546707
    [Abstract] [Full Text] [Related]

  • 16. Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein.
    Zhang J, Frolov I, Russell SJ.
    J Gene Med; 2004 Oct 23; 6(10):1082-91. PubMed ID: 15368589
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Recombinant LuIII autonomous parvovirus as a transient transducing vector for human cells.
    Maxwell IH, Maxwell F, Rhode SL, Corsini J, Carlson JO.
    Hum Gene Ther; 1993 Aug 23; 4(4):441-50. PubMed ID: 8399491
    [Abstract] [Full Text] [Related]

  • 19. Novel strategy for generation and titration of recombinant adeno-associated virus vectors.
    Shiau AL, Liu PS, Wu CL.
    J Virol; 2005 Jan 23; 79(1):193-201. PubMed ID: 15596815
    [Abstract] [Full Text] [Related]

  • 20. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A, Tjuvajev JG, Dubrovin M, Akhurst T, Balatoni J, Beattie B, Joshi R, Finn R, Larson SM, Herrlinger U, Pechan PA, Chiocca EA, Breakefield XO, Blasberg RG.
    Cancer Res; 2001 Apr 01; 61(7):2983-95. PubMed ID: 11306477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.